Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franco Franceschini

Showing results (221-230 of 231) with videos related to

Pageof 24
Sort By:
Current Pharmaceutical Design|September 3, 2021
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing TreatmentsClodoveo Ferri, Dilia Giuggioli, Vincenzo Raimondo, et al.
RMD Open|May 13, 2026
Clinical and serological features of triple autoantibody-negative patients with systemic sclerosis: insights from the multicentric SPRING registry of the Italian Society for RheumatologyVeronica Batani, Ilaria Cavazzana, Martina Orlandi, et al.
Current Pharmaceutical Design|June 21, 2022
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing TherapiesClodoveo Ferri, Vincenzo Raimondo, Laura Gragnani, et al.
Arthritis Care & Research|December 30, 2025
MYCOPHENOLATE MOFETIL TREATMENT REDUCES THE RISK OF TREATMENT ESCALATION DUE TO VASCULAR COMPLICATIONS IN LIMITED CUTANEOUS SYSTEMIC SCLEROSIS: EMULATION OF A TARGET TRIAL FROM ITALIAN RHEUMATOLOGY SOCIETY SPRING REGISTRYEnrico De Lorenzis, Gerlando Natalello, Rossella De Angelis, et al.
Clinical and Experimental Rheumatology|August 4, 2017
Timing of onset affects arthritis presentation pattern in antisyntethase syndromeMiguel A González-Gay, Carlomaurizio Montecucco, Albert Selva-O'Callaghan, et al.
Frontiers in Medicine|July 28, 2022
Development and Implementation of the AIDA International Registry for Patients With VEXAS SyndromeAntonio Vitale, Valeria Caggiano, Francesca Della Casa, et al.
Frontiers in Medicine|September 26, 2022
The Autoinflammatory Diseases Alliance Registry of monogenic autoinflammatory diseasesCarla Gaggiano, Antonio Vitale, Abdurrahman Tufan, et al.
Rheumatology (Oxford, England)|October 25, 2022
Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD studyMrinalini Dey, Naveen R, Elena Nikiphorou, et al.
RMD Open|April 25, 2024
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it studyLaura Andreoli, Maria Chiara Gerardi, Maria Gerosa, et al.
Clinical and Experimental Rheumatology|February 24, 2022
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodiesLorenzo Cavagna, Federica Meloni, Alain Meyer, et al.
Pageof 24

Showing results (221-230 of 231) with videos related to

Sort By:
Pageof 24
Current Pharmaceutical Design|September 3, 2021
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing TreatmentsClodoveo Ferri, Dilia Giuggioli, Vincenzo Raimondo, et al.
RMD Open|May 13, 2026
Clinical and serological features of triple autoantibody-negative patients with systemic sclerosis: insights from the multicentric SPRING registry of the Italian Society for RheumatologyVeronica Batani, Ilaria Cavazzana, Martina Orlandi, et al.
Current Pharmaceutical Design|June 21, 2022
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing TherapiesClodoveo Ferri, Vincenzo Raimondo, Laura Gragnani, et al.
Arthritis Care & Research|December 30, 2025
MYCOPHENOLATE MOFETIL TREATMENT REDUCES THE RISK OF TREATMENT ESCALATION DUE TO VASCULAR COMPLICATIONS IN LIMITED CUTANEOUS SYSTEMIC SCLEROSIS: EMULATION OF A TARGET TRIAL FROM ITALIAN RHEUMATOLOGY SOCIETY SPRING REGISTRYEnrico De Lorenzis, Gerlando Natalello, Rossella De Angelis, et al.
Clinical and Experimental Rheumatology|August 4, 2017
Timing of onset affects arthritis presentation pattern in antisyntethase syndromeMiguel A González-Gay, Carlomaurizio Montecucco, Albert Selva-O'Callaghan, et al.
Frontiers in Medicine|July 28, 2022
Development and Implementation of the AIDA International Registry for Patients With VEXAS SyndromeAntonio Vitale, Valeria Caggiano, Francesca Della Casa, et al.
Frontiers in Medicine|September 26, 2022
The Autoinflammatory Diseases Alliance Registry of monogenic autoinflammatory diseasesCarla Gaggiano, Antonio Vitale, Abdurrahman Tufan, et al.
Rheumatology (Oxford, England)|October 25, 2022
Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD studyMrinalini Dey, Naveen R, Elena Nikiphorou, et al.
RMD Open|April 25, 2024
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it studyLaura Andreoli, Maria Chiara Gerardi, Maria Gerosa, et al.
Clinical and Experimental Rheumatology|February 24, 2022
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodiesLorenzo Cavagna, Federica Meloni, Alain Meyer, et al.
Pageof 24